Dr. Leonard Schleifer, Regeneron Pharmaceuticals president/CEO, discusses the strategies behind his company's products, and why people using the same drug are switching to his company versus another.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT